ArticleJournal of virology2026
RPSA enhances African swine fever virus entry via caveola-mediated endocytic pathway.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
African swine fever virus (ASFV) poses a severe threat to the global pig industry, yet the precise mechanisms of its entry into host cells are not fully understood. In this study, we identified the host ribosomal protein SA (RPSA), a protein located in lipid rafts, as a critical viral receptor that facilitates ASFV entry. Immunoprecipitation-mass spectrometry (IP-MS) screening results identified RPSA as a binding partner of the ASFV capsid protein pE120R, which was further confirmed by co-immunoprecipitation (Co-IP) and immunofluorescence assays (IFA) in ASFV-infected cells. Moreover, knockdown of RPSA expression in porcine alveolar macrophages (PAMs) by siRNA significantly reduced ASFV attachment and internalization. In contrast, ectopic overexpression of RPSA in permissive CV-1 cells enhanced the attachment and internalization of ASFV virions. Additionally, we observed that both pharmacological inhibition of caveola-mediated endocytosis (CavME) with nystatin and genetic knockdown of caveolin-1 (CAV1) decreased caveola-mediated ASFV virions endocytosis and internalization. Mechanistically, RPSA interacts with CAV1, a major structural protein of caveolae. Domain mapping showed that pE120R mainly binds to the LR2 and LR3 domains of RPSA, while RPSA interacts with CAV1 via its 16B domain, forming a pE120R-RPSA-CAV1 complex that facilitates ASFV entry. Overall, these results demonstrate that RPSA works as a potential host receptor linking ASFV pE120R to the CAV1-mediated endocytic pathway, facilitating viral entry through caveola-mediated endocytosis. These findings advance our understanding of ASFV entry mechanism and offer a potential target for antiviral strategies against ASFV. IMPORTANCE: African swine fever threatens the global pig industry, yet its entry route remains unclear. Here, host ribosomal protein SA (RPSA) was identified as a binding partner of ASFV capsid protein pE120R. Knockdown of RPSA expression using siRNA in porcine alveolar macrophages reduced ASFV attachment and internalization, whereas ectopic overexpression in CV-1 cells enhanced the uptake of ASFV virions. Pharmacological blockade of caveola-mediated endocytosis (CavME) with nystatin or genetic silencing of caveolin-1 (CAV1) similarly impaired infection, indicating that ASFV entry into its target cells is CavME dependent. Domain mapping showed that pE120R binds LR2 and LR3 of RPSA, while RPSA uses its 16B domain to recruit CAV1, assembling a pE120R-RPSA-CAV1 entry complex. Thus, RPSA bridges ASFV to the CAV1-driven caveolar pathway. These findings define a novel receptor-mediated entry mechanism for ASFV virions and reveal that RPSA-CAV1 pathway may be an actionable antiviral target.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.